These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The results of using high-dose methotrexate in treating osteogenic sarcoma].
    Author: Perevodchikova NI, Eremina LA, Manziuk LV, Siniukov PA, Fedenko AN, Singin AS, Moldovanova LK.
    Journal: Vopr Onkol; 1990; 36(6):667-71. PubMed ID: 2378085.
    Abstract:
    The interim results of the use of high-dose methotrexate with leucovorin rescue for the treatment of 26 patients with osteogenic sarcoma are discussed. Preoperative chemotherapy was followed by marked regression of primary tumor in one out of seven patients with localized disease. In that group, metastasis-free period lasted 2, 3, 10+, 12, 17+ and 24+ months. Response was observed in two out of 19 (10.6%) cases of metastases. Toxic side-effects were moderate and were mainly nausea (38.5% of patients), vomiting (26.9%), elevation of serum transaminase levels (38.5%) and fever (30.7% of cases).
    [Abstract] [Full Text] [Related] [New Search]